Skp2 protein expression in soft tissue sarcomas

被引:55
作者
Oliveira, AM
Okuno, SH
Nascimento, AG
Lloyd, RV
机构
[1] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA
关键词
D O I
10.1200/JCO.2003.05.112
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: p45 S phase kinase-associated protein-2 (p45(skp2)), a member of the F-box family of proteins, is an important component of the Skp1-Cullin-F-box protein (SCF) ubiquitin-ligase complex (SCFskp2). The latter has been implicated in the ubiquitination and degradation of p27(kip1) (p27) and G(1)-S cell cycle progression. The expression and prognostic role of Skp2 in a large series of soft tissue sarcomas has not been previously investigated. Methods: Clinicopathologic features and immunohistochemical expression of Skp2, p27, and Ki-67 proteins were 2 cases of soft tissue sarcomas (American Joint Committee on Cancer stages II and III). Survival analyses were performed using the Kaplan-Meier method and the Cox regression model. Results: The male to female ratio was 1.2:1, and the median age at the diagnosis was 53 years. The tumors were predominantly located in the lower extremities (n = 163; 90%) and had a median size of 9 cm. High Skp2 expression (greater than or equal to 10% of the cells) was identified in 68 tumors (37%), and was correlated with high grade histology (P = .002) and Ki-67 proliferative index (r = 0.44; P < .0001), but not with p27 expression (r = -0.02; P = .80). By univariate analysis, high Skp2 expression was associated with decreased metastasis-free, disease-free, and overall survival. In a multivariate model, high Skp2 expression was an independent predictor for decreased local recurrence-free, disease-free, and overall survival. Conclusion: These results indicate that Skp2 expression is associated with cell proliferation and a worse prognosis in soft tissue sarcomas. The lack of an inverse correlation between Skp2 and p27 suggests that additional molecular events associated with either Skp2 expression or p27 proteolysis may be operating in these tumors. (C) 2003 by American Society of Clinical Oncology.
引用
收藏
页码:722 / 727
页数:6
相关论文
共 46 条
[1]  
*AJCC, 1997, AJCC CANC STAG MAN
[2]   DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[3]   Alterations of cell cycle regulators in localized synovial sarcoma - A multifactorial study with prognostic implications [J].
Antonescu, CR ;
Leung, DH ;
Dudas, M ;
Ladanyi, M ;
Brennan, M ;
Woodruff, JM ;
Cordon-Cardo, C .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :977-983
[4]   Mammalian G1- and S-phase checkpoints in response to DNA damage [J].
Bartek, J ;
Lukas, J .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (06) :738-747
[5]   p27 destruction: Cks1 pulls the trigger [J].
Bartek, J ;
Lukas, J .
NATURE CELL BIOLOGY, 2001, 3 (04) :E95-E98
[6]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[7]  
Collett D, 2014, MODELLING SURVIVAL D
[8]   The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27 [J].
Ganoth, D ;
Bornstein, G ;
Ko, TK ;
Larsen, B ;
Tyers, M ;
Pagano, M ;
Hershko, A .
NATURE CELL BIOLOGY, 2001, 3 (03) :321-324
[9]   Skp2 is oncogenic and overexpressed in human cancers [J].
Gstaiger, M ;
Jordan, R ;
Lim, M ;
Catzavelos, C ;
Mestan, J ;
Slingerland, J ;
Krek, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) :5043-5048
[10]   Degradation of p27Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway [J].
Hara, T ;
Kamura, T ;
Nakayama, K ;
Oshikawa, K ;
Hatakeyama, S ;
Nakayama, KI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :48937-48943